StockData
Alector, Inc. logo

Alector, Inc. (ALEC) stock

ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$2.56−0.01 (-0.39%)

Close on Nov 17, 2026Market cap $285.84MP/E –Yield –

Alector price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alector's price to sales ratio was 21.2× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 1.2× to 21.2×, with a median of 4.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.2×+18.8
2025Dec 31, 20252.4×−0.6
2024Dec 31, 20243.0×−4.0
2023Dec 29, 20237.0×+1.3
2022Dec 30, 20225.7×−2.6
2021Dec 31, 20218.3×−42.7
2020Dec 31, 202051.0×+2.3
2019Dec 31, 201948.7×–

More Alector figures

See a number that looks wrong?